-+ 0.00%
-+ 0.00%
-+ 0.00%

Amphastar Pharmaceuticals publishes investor presentation outlining shift to proprietary and biosimilar drug pipeline mix at 85%

Reuters·03/10/2026 20:43:09

Please log in to view news